Home/Granite Bio/Gijs van den Brink

GV

Gijs van den Brink

Chief Scientific Officer

Therapeutic Areas

Inflammation Autoimmunity Fibrosis

Granite Bio Pipeline

Drug	Indication	Phase
GRT-001	Inflammatory Bowel Disease (Autoimmunity/Inflammation)	Phase 1b
GRT-002	Itch, Allergy, Inflammation (Type II Inflammation)	Preclinical

Leadership Team at Granite Bio

Patrick Loustau

President and Chief Executive Officer

Chief Medical Officer

Chairman of the Board

View full Granite Bio profile